Structural and SP1-binding Analysis of Promoter of LAPTM4β, A Novel Gene Associated with Hepatocellular Carcinoma

XUE Shi-Lin,ZHANG Qing-Yun,ZHOU Rou-Li
DOI: https://doi.org/10.3969/j.issn.1007-7626.2007.01.008
2007-01-01
Abstract:To investigate the important transcription factors that function in the lysosome-associated protein transmembrane 4 beta (LAPTM4β) promoter and make a basic research for the upregulation of LAPTM4β in hepatocellular carcinoma, hepatocellular carcinomar derived cells HepG2 cells were transfected with promoter plasmids of LAPTM4β and luciferase reporter assays were applied to identify the core promoter of LAPTM4β; electrophoretic mobility shift assay (EMSA ) was applied to identify the important transcription factor that regulate the LAPTM4β promoter. HepG2 cells were transfected with six different lengths of promoter plasmids of LAPTM4β. Luciferase reporter assays showed that the fragment(PF3)558 bp upstream of the origin site of transcription had the highest promotive activity. As indicated by the Object-oriented Transcription Factors Database, there were multiple putative transcription factor binding sites in this region (PF3). Among of these transcription binding sites, there was a SP1 binding site. As indicated by EMSA, the oligonucleotides that contain the SP1 binding sites can bind to the nuclear extract of HepG2 and SMMC7721 cells. The binding could be competed by the 50 or 100 molar excess unlabeled oligonucleotides competitor. It was concluded that the fragment(PF3)558 bp upstream of the origin site of transcription was the core promoter of LAPTM4β. The oligonucleotides that contain the SP1 binding sites in the core promoter can bind to the nuclear extracts of hepatocellular related cells.
What problem does this paper attempt to address?